Skip to menu Skip to content Skip to footer

2023

Journal Article

TLQP-21 is a low potency partial C3aR activator on human primary macrophages

Li, Xaria X., Lee, John D., Lee, Han S., Clark, Richard J. and Woodruff, Trent M. (2023). TLQP-21 is a low potency partial C3aR activator on human primary macrophages. Frontiers in Immunology, 14 1086673, 1-10. doi: 10.3389/fimmu.2023.1086673

TLQP-21 is a low potency partial C3aR activator on human primary macrophages

2023

Conference Publication

Dietary resistant starch alters gut microbiota, microbially produced metabolites and albuminuria in diabetic mice

Snelson, M., Tan, S. M., Kumar, V., Woodruff, T. and Coughlan, M. T. (2023). Dietary resistant starch alters gut microbiota, microbially produced metabolites and albuminuria in diabetic mice. 46th Annual Scientific Meeting of the Nutrition Society of Australia, Perth, WA, Australia, 29 November – 2 December 2022. Cambridge, United Kingdom: Cambridge University Press. doi: 10.1017/s0029665123001921

Dietary resistant starch alters gut microbiota, microbially produced metabolites and albuminuria in diabetic mice

2022

Journal Article

Valproic acid attenuates cellular senescence in diabetic kidney disease through the inhibition of complement C5a receptors

Coughlan, Melinda T., Ziemann, Mark, Laskowski, Adrienne, Woodruff, Trent M. and Tan, Sih Min (2022). Valproic acid attenuates cellular senescence in diabetic kidney disease through the inhibition of complement C5a receptors. Scientific Reports, 12 (1) 20278, 1-10. doi: 10.1038/s41598-022-24851-w

Valproic acid attenuates cellular senescence in diabetic kidney disease through the inhibition of complement C5a receptors

2022

Journal Article

Success in navigating hurdles to oral delivery of a bioactive peptide complement antagonist through use of nanoparticles to increase bioavailability and in vivo efficacy (Adv. Therap. 12/2022)

Xu, Weizhi, Kumar, Vinod, Cui, Cedric S., Li, Xaria X., Whittaker, Andrew K., Xu, Zhi Ping, Smith, Maree T., Woodruff, Trent M. and Han, Felicity Y. (2022). Success in navigating hurdles to oral delivery of a bioactive peptide complement antagonist through use of nanoparticles to increase bioavailability and in vivo efficacy (Adv. Therap. 12/2022). Advanced Therapeutics, 5 (12) 2270030, 1-1. doi: 10.1002/adtp.202270030

Success in navigating hurdles to oral delivery of a bioactive peptide complement antagonist through use of nanoparticles to increase bioavailability and in vivo efficacy (Adv. Therap. 12/2022)

2022

Journal Article

Complement system inhibition modulates the inflammation induced by the venom of Premolis semirufa, an Amazon rainforest moth caterpillar

Gabrili, Joel J. M., Villas-Boas, Isadora Maria, Pidde, Giselle, Squaiella-Baptistão, Carla Cristina, Woodruff, Trent M. and Tambourgi, Denise V. (2022). Complement system inhibition modulates the inflammation induced by the venom of Premolis semirufa, an Amazon rainforest moth caterpillar. International Journal of Molecular Sciences, 23 (21) 13333, 1-20. doi: 10.3390/ijms232113333

Complement system inhibition modulates the inflammation induced by the venom of Premolis semirufa, an Amazon rainforest moth caterpillar

2022

Journal Article

Synthetic oligodeoxynucleotide CpG motifs activate human complement through their backbone structure and induce complement-dependent cytokine release

de Boer, Eline, Sokolova, Marina, Quach, Huy Q., McAdam, Karin E., Götz, Maximilian P., Chaban, Viktoriia, Vaage, Jarle, Fageräng, Beatrice, Woodruff, Trent M., Garred, Peter, Nilsson, Per H., Mollnes, Tom E. and Pischke, Søren E. (2022). Synthetic oligodeoxynucleotide CpG motifs activate human complement through their backbone structure and induce complement-dependent cytokine release. The Journal of Immunology, 209 (9), 1760-1767. doi: 10.4049/jimmunol.2101191

Synthetic oligodeoxynucleotide CpG motifs activate human complement through their backbone structure and induce complement-dependent cytokine release

2022

Journal Article

Potential mechanisms to modify impaired glucose metabolism in neurodegenerative disorders

McDonald, Tanya S., Lerskiatiphanich, Titaya, Woodruff, Trent M., McCombe, Pamela A. and Lee, John D. (2022). Potential mechanisms to modify impaired glucose metabolism in neurodegenerative disorders. Journal of Cerebral Blood Flow and Metabolism, 43 (1), 26-43. doi: 10.1177/0271678x221135061

Potential mechanisms to modify impaired glucose metabolism in neurodegenerative disorders

2022

Journal Article

Success in navigating hurdles to oral delivery of a bioactive peptide complement antagonist through use of nanoparticles to increase bioavailability and in vivo efficacy

Xu, Weizhi, Kumar, Vinod, Cui, Cedric S., Li, Xaria X., Whittaker, Andrew K., Xu, Zhi Ping, Smith, Maree T., Woodruff, Trent M. and Han, Felicity Y (2022). Success in navigating hurdles to oral delivery of a bioactive peptide complement antagonist through use of nanoparticles to increase bioavailability and in vivo efficacy. Advanced Therapeutics, 5 (12) 2200109, 2200109. doi: 10.1002/adtp.202200109

Success in navigating hurdles to oral delivery of a bioactive peptide complement antagonist through use of nanoparticles to increase bioavailability and in vivo efficacy

2022

Journal Article

SARS-CoV-2 triggers complement activation through interactions with heparan sulfate

Lo, Martin W., Amarilla, Alberto A., Lee, John D., Albornoz, Eduardo A., Modhiran, Naphak, Clark, Richard J., Ferro, Vito, Chhabra, Mohit, Khromykh, Alexander A., Watterson, Daniel and Woodruff, Trent M. (2022). SARS-CoV-2 triggers complement activation through interactions with heparan sulfate. Clinical and Translational Immunology, 11 (8) e1413, e1413. doi: 10.1002/cti2.1413

SARS-CoV-2 triggers complement activation through interactions with heparan sulfate

2022

Journal Article

Nucleocapsid specific diagnostics for the detection of divergent SARS-CoV-2 variants

Isaacs, Ariel, Amarilla, Alberto A., Aguado, Julio, Modhiran, Naphak, Albornoz, Eduardo A., Baradar, Alireza A., McMillan, Christopher L. D., Choo, Jovin J. Y., Idris, Adi, Supramaniam, Aroon, McMillan, Nigel A. J., Muller, David A., Young, Paul R., Woodruff, Trent M., Wolvetang, Ernst J., Chappell, Keith J. and Watterson, Daniel (2022). Nucleocapsid specific diagnostics for the detection of divergent SARS-CoV-2 variants. Frontiers in Immunology, 13 926262, 926262. doi: 10.3389/fimmu.2022.926262

Nucleocapsid specific diagnostics for the detection of divergent SARS-CoV-2 variants

2022

Journal Article

Thrombin differentially modulates the acute inflammatory response to Escherichia coli and Staphylococcus aureus in human whole blood

Johnson, Christina, Quach, Huy Quang, Lau, Corinna, Ekholt, Karin, Espevik, Terje, Woodruff, Trent M., Pischke, Søren Erik, Mollnes, Tom Eirik and Nilsson, Per H. (2022). Thrombin differentially modulates the acute inflammatory response to Escherichia coli and Staphylococcus aureus in human whole blood. The Journal of Immunology, 208 (12), 2771-2778. doi: 10.4049/jimmunol.2101033

Thrombin differentially modulates the acute inflammatory response to Escherichia coli and Staphylococcus aureus in human whole blood

2022

Journal Article

Bothrops jararaca snake venom inflammation induced in human whole blood: role of the complement system

Leonel, Thyago Bispo, Gabrili, Joel José Megale, Squaiella-Baptistão, Carla Cristina, Woodruff, Trent M., Lambris, John D. and Tambourgi, Denise V. (2022). Bothrops jararaca snake venom inflammation induced in human whole blood: role of the complement system. Frontiers in Immunology, 13 885223, 1-16. doi: 10.3389/fimmu.2022.885223

Bothrops jararaca snake venom inflammation induced in human whole blood: role of the complement system

2022

Journal Article

Complement drives circuit modulation in the adult brain

Parker, Sandra E., Bellingham, Mark C. and Woodruff, Trent M. (2022). Complement drives circuit modulation in the adult brain. Progress in Neurobiology, 214 102282, 102282. doi: 10.1016/j.pneurobio.2022.102282

Complement drives circuit modulation in the adult brain

2022

Journal Article

Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis

Ortiz-Espinosa, Sergio, Morales, Xabier, Senent, Yaiza, Alignani, Diego, Tavira, Beatriz, Macaya, Irati, Ruiz, Borja, Moreno, Haritz, Remírez, Ana, Sainz, Cristina, Rodriguez-Pena, Alejandro, Oyarbide, Alvaro, Ariz, Mikel, Andueza, Maria P., Valencia, Karmele, Teijeira, Alvaro, Hoehlig, Kai, Vater, Axel, Rolfe, Barbara, Woodruff, Trent M., Lopez-Picazo, Jose Maria, Vicent, Silvestre, Kochan, Grazyna, Escors, David, Gil-Bazo, Ignacio, Perez-Gracia, Jose Luis, Montuenga, Luis M., Lambris, John D., Ortiz de Solorzano, Carlos ... Pio, Ruben (2022). Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis. Cancer Letters, 529, 70-84. doi: 10.1016/j.canlet.2021.12.027

Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis

2022

Journal Article

Reduced Growth, Altered Gut Microbiome and Metabolite Profile, and Increased Chronic Kidney Disease Risk in Young Pigs Consuming a Diet Containing Highly Resistant Protein

Murray, Margaret, Coughlan, Melinda T., Gibbon, Anne, Kumar, Vinod, Marques, Francine Z., Selby-Pham, Sophie, Snelson, Matthew, Tsyganov, Kirill, Williamson, Gary, Woodruff, Trent M., Wu, Tong and Bennett, Louise E. (2022). Reduced Growth, Altered Gut Microbiome and Metabolite Profile, and Increased Chronic Kidney Disease Risk in Young Pigs Consuming a Diet Containing Highly Resistant Protein. Frontiers in Nutrition, 9 816749, 816749. doi: 10.3389/fnut.2022.816749

Reduced Growth, Altered Gut Microbiome and Metabolite Profile, and Increased Chronic Kidney Disease Risk in Young Pigs Consuming a Diet Containing Highly Resistant Protein

2022

Conference Publication

Identification of potent small peptides targeting human C3a receptor

Deerain, Nick, Kumar, Vinod, Clark, Richard and Woodruff, Trent (2022). Identification of potent small peptides targeting human C3a receptor. ICW – 2021 Virtual Workshop of the International Complement Society (ICS), Virtual, 7-10 December 2021. Oxford, United Kingdom: Elsevier.

Identification of potent small peptides targeting human C3a receptor

2022

Conference Publication

Immunoregulatory role for complement receptors in murine breast cancer

Rolfe, Barbara, Sonderegger, Stefan, McGirr, Crystal and Woodruff, Trent (2022). Immunoregulatory role for complement receptors in murine breast cancer. 28th Virtual International Complement Workshop (ICW) of the International-Complement-Society (ICS), Virtual, 6-10 December 2021. Oxford, United Kingdom: Elsevier.

Immunoregulatory role for complement receptors in murine breast cancer

2022

Book Chapter

Neuroinflammation in Huntington’s

Lee, John D., Lo, Martin W., Fung, Jenny N. T. and Woodruff, Trent M. (2022). Neuroinflammation in Huntington’s. Neurodegenerative Diseases Biomarkers. (pp. 215-233) edited by Philip V. Peplow, Bridget Martinez and Thomas A. Gennarelli. New York, NY, United States: Springer US. doi: 10.1007/978-1-0716-1712-0_9

Neuroinflammation in Huntington’s

2021

Journal Article

In vivo pharmacodynamic method to assess complement C5a receptor antagonist efficacy

Cui, Cedric S., Kumar, Vinod, Gorman, Declan M., Clark, Richard J., Lee, John D. and Woodruff, Trent M. (2021). In vivo pharmacodynamic method to assess complement C5a receptor antagonist efficacy. ACS Pharmacology and Translational Science, 5 (1) acsptsci.1c00227, 41-51. doi: 10.1021/acsptsci.1c00227

In vivo pharmacodynamic method to assess complement C5a receptor antagonist efficacy

2021

Conference Publication

An in-vivo pharmacodynamic method to investigate complement C5a receptor antagonists

Cui, Cedric, Kumar, Vinod, Gorman, Declan, Clark, Richard, Lee, John and Woodruff, Trent (2021). An in-vivo pharmacodynamic method to investigate complement C5a receptor antagonists. ICW – 2021 Virtual Workshop of the International Complement Society (ICS), Virtual, 7-10 December 2021. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.molimm.2021.11.020

An in-vivo pharmacodynamic method to investigate complement C5a receptor antagonists